Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study record. The header and footer remain visible, but the actual study details cannot be retrieved.
    Difference
    18%
    Check dated 2026-09-19T17:55:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A note about a 2017 NIH grant/contract was added, and the site revision was updated to v3.6.6, replacing v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-29T13:25:43.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.6.4 to v3.6.5, representing a new revision in the page's version history rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-08-07T23:32:47.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a routine platform/content-management update.
    Difference
    0.0%
    Check dated 2026-07-24T16:10:29.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Publications section updated with a new ATHENA MONO publication citation by Kristeleit et al. (Ann Oncol. 2026). The revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-02T20:29:38.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.6.2, replacing v3.6.0, indicating a minor maintenance update with no changes to the study information visible to users.
    Difference
    0.0%
    Check dated 2026-06-25T22:02:03.000Z thumbnail image

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.